Sector Update: Health Care Stocks Mixed Pre-Bell Thursday

MT Newswires Live2025-07-17

Health care stocks were mixed pre-bell Thursday with the Health Care Select Sector SPDR Fund (XLV) 0.3% lower and the iShares Biotechnology ETF (IBB) advancing by 0.2% recently.

Abbott Laboratories (ABT) shares were down 6% after the company narrowed its 2025 adjusted earnings guidance to between $5.10 to $5.20 per diluted share, from a previous range of $5.05 to $5.25. The company also issued Q3 adjusted EPS outlook below analysts' expectations.

Sarepta Therapeutics (SRPT) shares were advancing by more than 27% after the company said it is launching a restructuring plan that includes cutting expenses, delivering $400 million in annual cost savings. The company said the plan includes a 36% workforce reduction of about 500 employees.

Elevance Health (ELV) shares were down more than 2% after the company reported a decline in Q2 adjusted earnings.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2552481024?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-07-17 21:15","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2552481024","market":"hk","top_or_hot":-1,"title":"Sector Update: Health Care Stocks Mixed Pre-Bell Thursday","media":"MT Newswires Live","content":"<html><body><p> Health care stocks were mixed pre-bell Thursday with the <a href=\"https://laohu8.com/S/XLV\">Health Care Select Sector SPDR Fund</a> (XLV) 0.3% lower and the <a href=\"https://laohu8.com/S/IBB\">iShares Biotechnology ETF</a> (IBB) advancing by 0.2% recently.</p><p><a href=\"https://laohu8.com/S/ABT\">Abbott Laboratories</a> (ABT) shares were down 6% after the company narrowed its 2025 adjusted earnings guidance to between $5.10 to $5.20 per diluted share, from a previous range of $5.05 to $5.25. The company also issued Q3 adjusted EPS outlook below analysts' expectations.</p><p><a href=\"https://laohu8.com/S/SRPT\">Sarepta Therapeutics</a> (SRPT) shares were advancing by more than 27% after the company said it is launching a restructuring plan that includes cutting expenses, delivering $400 million in annual cost savings. The company said the plan includes a 36% workforce reduction of about 500 employees.</p><p><a href=\"https://laohu8.com/S/ELV\">Elevance Health</a> (ELV) shares were down more than 2% after the company reported a decline in Q2 adjusted earnings.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Sector Update: Health Care Stocks Mixed Pre-Bell Thursday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSector Update: Health Care Stocks Mixed Pre-Bell Thursday\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-07-17 21:15</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Health care stocks were mixed pre-bell Thursday with the <a href=\"https://laohu8.com/S/XLV\">Health Care Select Sector SPDR Fund</a> (XLV) 0.3% lower and the <a href=\"https://laohu8.com/S/IBB\">iShares Biotechnology ETF</a> (IBB) advancing by 0.2% recently.</p><p><a href=\"https://laohu8.com/S/ABT\">Abbott Laboratories</a> (ABT) shares were down 6% after the company narrowed its 2025 adjusted earnings guidance to between $5.10 to $5.20 per diluted share, from a previous range of $5.05 to $5.25. The company also issued Q3 adjusted EPS outlook below analysts' expectations.</p><p><a href=\"https://laohu8.com/S/SRPT\">Sarepta Therapeutics</a> (SRPT) shares were advancing by more than 27% after the company said it is launching a restructuring plan that includes cutting expenses, delivering $400 million in annual cost savings. The company said the plan includes a 36% workforce reduction of about 500 employees.</p><p><a href=\"https://laohu8.com/S/ELV\">Elevance Health</a> (ELV) shares were down more than 2% after the company reported a decline in Q2 adjusted earnings.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ABT","symbol_name":"雅培","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2552481024","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2552481024","pubTimestamp":1752758112,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Health care stocks were mixed pre-bell Thursday with the Health Care Select Sector SPDR Fund (XLV) 0.3% lower and the iShares Biotechnology ETF (IBB) advancing by 0.2% recently.Abbott Laboratories (AB","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"ABT":"雅培","LU0187121727.USD":"FIDELITY SUSTAINABLE US EQUITY \"A\" (USD) INC","LU1720051017.SGD":"Allianz Global Artificial Intelligence AT Acc H2-SGD","LU2362541513.USD":"WELLINGTON NEXT GENERATION GLOBAL EQUITY \"A\" (USD) ACC","LU0266013472.USD":"AXA WF - Framlington Longevity Economy A Cap USD","SG9999001077.SGD":"United International Growth Fund SGD","LU1280957306.USD":"THREADNEEDLE (LUX) US CONTRARIAN CORE EQUITIES \"AUP\" (USD) INC","LU1489326972.SGD":"First Eagle Amundi International AHS-MD SGD-H","IBB":"生物科技指数ETF-iShares Nasdaq","LU2237957902.USD":"NIKKO AM GLOBAL EQUITY \"F\" (USD) ACC","LU0114720955.EUR":"SUSTAINABLE GLOBAL HEALTH CARE \"A\" INC","LU0985489474.SGD":"First Eagle Amundi International AHS-C SGD-H","LU0320765489.SGD":"FTIF - Franklin Mutual US Value A Acc SGD","LU2362540622.SGD":"WELLINGTON NEXT GENERATION GLOBAL EQUITY \"A\" (SGDHDG) ACC","LU0289739699.SGD":"AB INTERNATIONAL HEALTH CARE PORTFOLIO \"A\" (SGD) ACC","LU0433182093.SGD":"First Eagle Amundi International AS-C SGD","ELV":"Elevance Health","LU1023059063.AUD":"BGF WORLD HEALTHSCIENCE \"A2\" (AUDHDG) ACC","LU2592432038.USD":"WELLINGTON MULTI-ASSET HIGH INCOME \"A\" (USD) ACC","LU0234570918.USD":"高盛全球核心股票组合Acc Close","BK4581":"高盛持仓","LU0006306889.USD":"SCHRODER ISF US LARGE CAP \"A\" (USD) INC AV","LU2468319806.SGD":"MANULIFE GF HEALTHCARE \"AA\" (SGDHDG) ACC","LU0251142724.SGD":"Fidelity America A-SGD","BK4588":"碎股","BK4533":"AQR资本管理(全球第二大对冲基金)","LU0061474960.USD":"天利环球焦点基金AU Acc","XLV":"健康照护类股ETF-SPDR","LU1989763427.SGD":"CPR Invest - Food For Generations A2 Acc SGD-H","LU2108987350.USD":"UBS (LUX) EQUITY SICAV GLOBAL OPPORTUNITY SUSTAINABLE (USD) \"P\" (USD) ACC","LU1815333072.USD":"THREADNEEDLE (LUX) GLOBAL FOCUS \"AUP\" (USD) INC","LU1691799644.USD":"Amundi Funds Polen Capital Global Growth A2 (C) USD","ABT.AU":"Abundant Produce","IE00BFTCPJ56.SGD":"Janus Henderson Global Life Sciences A Acc SGD","IE0002141913.USD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I2\" (USD) ACC","IE00B2B36J28.USD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I1\" (USD) INC","LU2505996681.GBP":"WELLINGTON MULTI-ASSET HIGH INCOME \"AM4H\" (GBPHDG) INC","LU2430703178.SGD":"WELLINGTON MULTI-ASSET HIGH INCOME \"AM4H\" (SGDHDG) INC","BK4154":"管理型保健护理","IE00BJT1NW94.SGD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"A2\" (SGDHDG) ACC","IE0009355771.USD":"骏利亨德森环球生命科技A Acc","SG9999002224.SGD":"Allianz Global High Payout SGD","SRPT":"Sarepta Therapeutics","LU2089984988.USD":"MANULIFE GF HEALTHCARE \"AA\" (USD) ACC","LU0106261372.USD":"SCHRODER ISF US LARGE CAP \"A\" ACC","LU1057294990.SGD":"Blackrock World Healthscience A2 SGD-H","LU2357305700.SGD":"Allianz Global Artificial Intelligence ET H2-SGD","LU0345770308.USD":"NINETY ONE GSF GLOBAL STRATEGIC EQUITY \"A\" (USD) ACC","SG9999011175.SGD":"Nikko AM Global Dividend Equity Dis SGD-H","LU1506573853.SGD":"MANULIFE GF GLOBAL EQUITY \"AA\" (SGD) INC"},"translate_title":"行业更新：医疗保健股周四盘前涨跌互现","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ABT":0.9,"SRPT":0.9,"ABT.AU":1,"IBB":0.9,"XLV":0.9,"ELV":0.9},"content_text":"Health care stocks were mixed pre-bell Thursday with the Health Care Select Sector SPDR Fund (XLV) 0.3% lower and the iShares Biotechnology ETF (IBB) advancing by 0.2% recently.Abbott Laboratories (ABT) shares were down 6% after the company narrowed its 2025 adjusted earnings guidance to between $5.10 to $5.20 per diluted share, from a previous range of $5.05 to $5.25. The company also issued Q3 adjusted EPS outlook below analysts' expectations.Sarepta Therapeutics (SRPT) shares were advancing by more than 27% after the company said it is launching a restructuring plan that includes cutting expenses, delivering $400 million in annual cost savings. The company said the plan includes a 36% workforce reduction of about 500 employees.Elevance Health (ELV) shares were down more than 2% after the company reported a decline in Q2 adjusted earnings.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2552481024","isCrawlerRequest":true}